Sigilon Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2023.
  • Sigilon Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2023 was -175 %, a 73% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Operating Margin for 2022 was -337 %, a 57.2% increase from 2021.
  • Sigilon Therapeutics, Inc. annual Operating Margin for 2021 was -788 %, a 100% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -175 +472 +73% Apr 1, 2023 Jun 30, 2023
Q1 2023 -256 +464 +64.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -337 +451 +57.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -433 +204 +32% Jul 1, 2022 Sep 30, 2022
Q2 2022 -646 -167 -34.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -719 -265 -58.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -788 -394 -100% Oct 1, 2021 Dec 31, 2021
Q3 2021 -637 Jul 1, 2021 Sep 30, 2021
Q2 2021 -479 Apr 1, 2021 Jun 30, 2021
Q1 2021 -455 Jan 1, 2021 Mar 31, 2021
Q4 2020 -394 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.